Capital Rx, a leading full-service pharmacy benefit manager (PBM) and pharmacy benefit administrator (PBA), has once again been recognized as one of the top digital health companies in New York. The company has been named to the 2024 New York Digital Health 100 (DH100) list, which showcases the most innovative and exciting companies in the digital health sector in New York.
The recognition comes as no surprise, as Capital Rx has consistently demonstrated its commitment to improving drug price visibility and patient outcomes through its enterprise health platform, JUDI®, and its aligned PBM model. This platform has been instrumental in driving efficiency for clients and redefining productivity and scale in healthcare administration.
“We are proud to be named to the New York Digital Health 100 for the fifth year in a row,” said AJ Loiacono, Co-Founder and CEO of Capital Rx. “Our mission to build the electronic infrastructure needed to deliver quality healthcare is at the core of everything we do. We are dedicated to improving the healthcare system, and this recognition further validates our efforts.”
This year’s Digital Health 100 list is especially significant as it marks the fifth year of its publication. Bunny Ellerin, Co-Founder and CEO of Digital Health New York (DHNY), emphasized the growth and evolution of the digital health ecosystem in New York over the past five years. She commended the recognized organizations for their ongoing commitment to innovation and transformation in driving healthcare forward.
Capital Rx experienced a highly successful year in 2023, achieving record growth and reaching several significant milestones. The company secured over $50 million in strategic funding, signed new Fortune 500 clients, and began processing Medicare claims through JUDI. As they continue into 2024, exciting partnerships and the introduction of new features and functionality in JUDI are expected.
Capital Rx’s inclusion in the New York Digital Health 100 for the fifth consecutive year solidifies its position as a leader and innovator in the digital health industry. The company’s dedication to improving drug price visibility and patient outcomes through its platform showcases its commitment to transforming the healthcare system for the better.
FAQ:
The source of the article is from the blog oinegro.com.br